Vaccines of the 21st century and vaccinomics: Data-enabled science meets global health to spark collective action for vaccine innovation

OMICS A Journal of Integrative Biology

Volumn 15, Issue 9, 2011, Pages 523-527

  Ozdemir, Vural ^a   Pang, Tikki ^b   Knoppers, Bartha M ^a   Avard, Denise ^a   Faraj, Samer A ^c   Zawati, Ma'n H ^a   Kolker, Eugene ^d,e,f  

^a MCGILL UNIVERSITY   (Canada)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c MCGILL UNIVERSITY   (Canada)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^e SEATTLE CHILDREN S HOSPITAL   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

BIOMICS; CELLULAR IMMUNITY; DRUG DESIGN; DRUG RESEARCH; HUMAN; HUMORAL IMMUNITY; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINOMICS;

CONSUMER PARTICIPATION; DIFFUSION OF INNOVATION; GENOMICS; HUMANS; INTERNATIONAL AGENCIES; PUBLIC HEALTH; PUBLIC OPINION; VACCINATION; VACCINES;

EID: 80052703586     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2011.03ed     Document Type: Review

References (42)

1. Avard, D., Stanton-Jean, M., Grégoire, G., and Page M. (2010). Public involvement in health genomics: the reality behind the policies. Int J Consum Stud 34, 508-524.
2. Brice, P. (2011). WHO grand challenges in genomics for developing countries. Public Health Genomics Foundation Newsletter, June 8, 2011. Available at: .org/news/8728/ (accessed June 27, 2011).
3. Burke, W., Burton, H., Hall, A.E., Karmali, M., Khoury, M.J., Knoppers, B., et al. (2010). Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and ''personalized'' medicine? Genet Med 12, 785-791.
4. Carlile, P.R. (2004). Transferring, translating, and transforming: an integrative framework for managing knowledge across boundaries. Organizat Sci 15, 555-568. (Pubitemid 39453864)
5. Condit, C. (2001). What is ''public opinion'' about genetics? Nat Rev Genet 2, 811-815.
6. Contandriopoulos, D., Denis, J.-L., and Langley, A. (2004). Defining the ''public'' in a public healthcare system. Hum Relat 57, 1573-1593.
7. Daar, A.S. (2010). Chronic non-communicable diseases as a threat for all: recent global initiatives. Sultan Qaboos Univ Med J 10, 306-309.
8. Einsiedel, E.F. (2011). Publics and vaccinomics: beyond public understanding of science. OMICS 15, this issue.
9. European Commission. (2007). EUR 22700-Science & Governance-Taking European Knowledge Society Seriously. Luxembourg: Office for Official Publications of the European Communities. Available at: http://ec.europa.eu/ research/science-society/document-library/pdf-06/european-knowledge-society-en. pdf (accessed June 27, 2011).
10. Faraj, S., and Yan, A. (2009). Boundary work in knowledge teams. Appl Psychol 94, 604-617.
11. Hayeems, R.Z., Miller, F.A., Li, L., and Bytautas J.P. (2011). Not so simple: a quasi-experimental study of how researchers adjudicate genetic research results. Eur J Hum Genet 19, 740-747.
12. Hotez, P.J. (2011). New antipoverty drugs, vaccines, and diagnostics: a research agenda for the US President's Global Health Initiative (GHI). PLoS Negl Trop Dis 5, e1133.
13. Jasanoff, S. (2006). States of Knowledge: The Co-Production of Science and Social Order. London: Routledge.
14. Kasperson, R.E. (1986). Six propositions on public participation and their relevance for risk communication. Risk Anal 6, 275-281. (Pubitemid 16032598)
15. Khoury, M.J., Bowen, S., Bradley, L.A., Coates, R., Dowling, N.F., Gwinn, M., et al. (2009). A decade of public health ge-nomics in the United States: Centers for Disease Control and Prevention 1997-2007. Public Health Genomics 12, 20-29.
16. Khoury, M.J. (2011). Public health genomics: the end of the beginning. Genet Med 13, 206-209.
17. Kickbusch, I. (2005). Tackling the political determinants of global health. BMJ 331, 246-247. (Pubitemid 41097904)
18. Kickbusch, I. (2011). Global health diplomacy: how foreign policy can influence health. BMJ 342, d3154.
19. Knoppers, B.M., Leroux, T., Doucet, H., Godard, B., Laberge, C., Stanton-Jean, M., et al. (2010). Framing genomics, public health research and policy: points to consider. Public Health Genomics 13, 224-234.
20. Kolker, E. (2011). Special issue on data-intensive science. OMICS 15, 197-198.
21. Lehoux, P. (2011). Moving beyond our mutual ignorance. Or, how would engaging the public benefit the personalized medicine community? Curr Pharmacogenomics Person Med 9, 76-79.
22. Majchrzak, A., More, P.H.B., and Faraj, S. (2011). Transcending knowledge differences in cross-functional teams. Organizat Sci. (in press).
23. Marmot, M. (2010). BMA presidency acceptance speech: fighting the alligators of health inequalities. BMJ 341, c3617.
24. National Science Foundation. (2011). Office of Cyberinfrastructure. Advisory Committee for Cyberinfrastucture (ACCI) Task Force Reports. Available at:oci/taskforces/ (accessed June 27, 2011).
25. Nowotny, H., Scott, P., and Gibbons, M. (2001). Re-Thinking Science: Knowledge and the Public in an Age of Uncertainty. Cambridge: Polity Press.
26. O'Leary, P., and Zimmern, R.L. (2010). Genomics and public health: translating research into public benefit. Public Health Genomics 13, 193-196.
27. Ommer, R., Wynne, B., Downey, R., Fisher, E., Marden, E., Kosseim, P., et al. (2011). Pathways to Integration. Vancouver: Genome British Columbia GSEAC Subcommittee on Pathways to Integration. Available at: www.genomebc.ca/index. php/download-file/view/611/910/ (accessed on June 27, 2011).
28. O'Neill, O. (2011). Broadening bioethics: clinical ethics, public health and global health. Nuffield Council on Bioethics Annual Lecture. Available at: broadening-bioethics-clinical-ethics-public-health-and-globalhealth (accessed June 27, 2011).
29. Ostrom, E. (1990). Governing the Commons: The Evolution of Institutions for Collective Action. Cambridge: Cambridge University Press.
30. Ozdemir, V. (2010). Pharmacogenomics: Reflections on the old and new social, ethical and policy issues in postgenomics medicine. In Pharmacogenomics in Psychiatry. Advances in Biological Psychiatry. M. Schwab, W. Kaschka, and E. Spina, eds. (Karger, Basel), pp. 12-29.
31. Ozdemir, V., Suarez-Kurtz, G., Stenne, R., Somogyi, A.A., Someya, T., Kayaalp, S.O., et al. (2009). Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of ''edge effect'' and cultivating an ethical bridge between omics innovations and society. OMICS 13, 43-61.
32. Pang, T. (2011). No Health Without Research-World Health Report for 2012. Available at: ofmedicine/2011/01/25/no-health-without-research-worldhealth- report-for-2012/ (accessed June 27, 2011).
33. Poland, G.A. (2007). Pharmacology, vaccinomics, and the second golden age of vaccinology. Clin Pharmacol Ther 82, 623-626. (Pubitemid 350114819)
34. Poland, G.A., Ovsyannikova, I.G., Jacobson, R.M., and Smith, D.I. (2007). Heterogeneity in vaccine immune response: The role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther 82, 653-664. (Pubitemid 350114830)
35. Program for Appropriate Technology in Health. (2011). Sparking Innovation to Save Lives: How the US Can Advance Global Health Through New Technologies. Washington, DC: Global Health Technologies Coalition.
36. Schofield, P.N., Eppig, J., Huala, E., de Angelis, M.H., Harvey, M., Davidson, D., et al. (2010). Sustaining the data and bioresource commons. Science 330, 592-593.
37. The White House, Office of the Press 2009 Statement by the President on Global Health Initiative May 5 press release Available at: http://www. whitehouse.gov/the-press-office/Statement-by-the-President-on-Global-Health- Initiative Secretary. accessed June 24, 2011
38. Thomas, C., and Moridani, M. (2010). Interindividual variations in the efficacy and toxicity of vaccines. Toxicology 278, 204-210.
39. University of California. (2009). The importance of the global health sector in California: an evaluation of the economic impact. Available at: .edu/docs/eir-final.pdf (accessed June 27, 2011).
40. Walport, M., and Brest, P. (2011). Sharing research data to improve public health. Lancet 377, 537-539.
41. Wynne, B. (2006). Public engagement as a means of restoring public trust in science- hitting the notes, but missing the music? Community Genet 9, 211-220. (Pubitemid 43854187)
42. Zawati, M., Hendy, M., and Joly, Y. (2011). Incidental findings in data intensive postgenomics science and legal liability of clinician-researchers: ready for vaccinomics? OMICS 15, this issue.